Roche, Novartis CEOs pull down $12M-plus each in 2021 pay

While crosstown rivals Roche and Novartis routinely rank among the world's top five drugmakers by revenue, their CEOs typically fall outside the ranks of the top-paid CEOs in the industry. As for 2021, the CEOs of the Swiss drugmakers each collected more than $12 million in total pay.